Changes in Resting-State Connectivity following Melody-Based Therapy in a Patient with Aphasia
Table 3
Treatment outcome measures for JV.
(a)
Sentence repetition (steps 1 to 3)
Mean % correctly produced syllables (SD)
Treated phrases ()
Untreated phrases ()
Pre-
71.34 (28.79)
64.60 (32.59)
Post-
96.78 (8.05)
61.55 (33.15)
8-week
93.33 (13.30)
74.11 (30.88)
values (Wilcoxon signed-rank test for related samples)
Treated post
Treated 8 weeks
Untreated post
Treated pre
Treated post
Alpha = 0.0167 (Bonferroni correction).
(b)
Sentence completion (step 4)
Mean number of syllables produced (SD)
Treated phrases ()
Untreated phrases ()
Pre-
1.44 (1.88)
1.78 (1.20)
Post-
4.22 (2.44)
4.78 (2.28)
8-week
2.78 (2.04)
3.78 (1.72)
values (Wilcoxon signed-rank test for related samples)
Treated post
Treated 8 weeks
Untreated post
Untreated 8 weeks
Treated pre
Treated post
Untreated pre
∧Approaching significance of Alpha = 0.01 (Bonferroni correction).
(c)
Answering questions (step 5)
Mean number of syllables produced (SD)
Treated phrases ()
Untreated phrases ()
Pre-
0.50 (1.08)
0.40 (0.97)
Post-
6.20 (2.90)
2.10 (3.03)
8-week
4.60 (3.06)
2.40 (3.13)
values (Wilcoxon signed-rank test for related samples)
Treated post
Treated 8 weeks
Untreated post
Untreated 8 weeks
Treated pre
Treated post
Untreated pre
Alpha = 0.01 (Bonferroni correction). Performance on treated and untreated phrases at pre-, post- and 8-week follow-up tests. Sentence repetition (steps 1–3; (a)), sentence completion (step 4, (b)), and probe questions (step 5, (c)) are presented. Statistical comparisons with Wilcoxon signed-rank test are indicated at the bottom of each panel.
